Nanovibronix Cash on Hand 2014-2024 | NAOV
Nanovibronix cash on hand from 2014 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Nanovibronix Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $3 |
| 2022 | $3 |
| 2021 | $8 |
| 2020 | $8 |
| 2019 | $1 |
| 2018 | $1 |
| 2017 | $4 |
| 2016 | $0 |
| 2015 | $2 |
| 2014 | $0 |
| 2013 | $0 |
| Nanovibronix Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1 |
| 2024-09-30 | $1 |
| 2024-06-30 | $2 |
| 2024-03-31 | $3 |
| 2023-12-31 | $3 |
| 2023-09-30 | $4 |
| 2023-06-30 | $0 |
| 2023-03-31 | $2 |
| 2022-12-31 | $3 |
| 2022-09-30 | $2 |
| 2022-06-30 | $4 |
| 2022-03-31 | $6 |
| 2021-12-31 | $8 |
| 2021-09-30 | $9 |
| 2021-06-30 | $6 |
| 2021-03-31 | $8 |
| 2020-12-31 | $8 |
| 2020-09-30 | $4 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $1 |
| 2019-09-30 | $2 |
| 2019-06-30 | $2 |
| 2019-03-31 | $0 |
| 2018-12-31 | $1 |
| 2018-09-30 | $2 |
| 2018-06-30 | $3 |
| 2018-03-31 | $3 |
| 2017-12-31 | $4 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $1 |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | $2 |
| 2015-09-30 | $2 |
| 2015-06-30 | $2 |
| 2015-03-31 | $3 |
| 2014-12-31 | $0 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.003B |
| NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.130B | 88.53 |
| Thermo Fisher Scientific (TMO) | United States | $161.926B | 19.59 |
| Alcon (ALC) | Switzerland | $45.995B | 31.08 |
| Edwards Lifesciences (EW) | United States | $44.288B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $40.945B | 47.06 |
| DexCom (DXCM) | United States | $32.980B | 50.98 |
| IQVIA Holdings (IQV) | United States | $26.068B | 14.60 |
| Mettler-Toledo (MTD) | United States | $24.462B | 29.09 |
| STERIS (STE) | Ireland | $22.711B | 25.97 |
| Waters (WAT) | United States | $21.365B | 30.14 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.057B | 0.00 |
| Hologic (HOLX) | United States | $12.729B | 13.83 |
| Sysmex ADR (SSMXY) | Japan | $11.601B | 0.00 |
| Penumbra (PEN) | United States | $11.465B | 89.99 |
| Masimo (MASI) | United States | $8.760B | 32.31 |
| Globus Medical (GMED) | United States | $8.012B | 18.79 |
| Teleflex (TFX) | United States | $5.603B | 9.25 |
| Glaukos (GKOS) | United States | $5.278B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.130B | 89.79 |
| PROCEPT BioRobotics (PRCT) | United States | $2.935B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.295B | 32.21 |
| Nihon Kohden (NHNKY) | Japan | $2.030B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $2.018B | 18.14 |
| Alphatec Holdings (ATEC) | United States | $1.859B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.541B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.133B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.050B | 5.58 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| SiBone (SIBN) | United States | $0.792B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.690B | 15.08 |
| IRadimed (IRMD) | United States | $0.677B | 34.34 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.588B | 9.14 |
| Beta Bionics (BBNX) | United States | $0.572B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.564B | 0.00 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.532B | 0.00 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.352B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.345B | 0.00 |
| Neuronetics (STIM) | United States | $0.293B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.91 |
| Alpha Tau Medical (DRTS) | Israel | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| 908 Devices (MASS) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.164B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| CVRx (CVRX) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |